At the IGTP TODAY
The Program of Advanced Therapies (PATH) of IGTP held an event on 5 November to showcase capabilities across the Can Ruti Campus, foster collaboration between research groups, clinical professionals and companies, and address challenges in bringing advanced therapies into clinical practice.
IGTP coordinates one of the selected projects and is involved in two others, focusing on the identification of biomarkers, treatment resistance and anti-tumour immune responses. Together, the three initiatives have received nearly €1.1 million in funding.
IGTP’s CARE Program held its fourth Annual Meeting on 22 October. The event brought together researchers and healthcare professionals to share projects and research activities, meet the new groups joining the program and review the work carried out so far.
A clinical trial involving 240 adolescents aged 12 to 17 has shown that HIPRA's COVID-19 vaccine, BIMERVAX®, administered as a booster dose, induces a broad immune response against different SARS-CoV-2 variants, comparable to that observed in adults and sustained for at least one year. The study, published in Pediatrics, was led by IrsiCaixa, IGTP, VHIR and HIPRA as part of the European RBDCOV project.
_edited_1792056506.png)
IGTP held a new event in collaboration with EATRIS, the European infrastructure for translational medicine, focusing this year on the role of artificial intelligence in biomarker research and precision medicine.
The Innomed community visited IDNEO to learn about its capabilities in device development, digital technologies and MedTech solutions. The visit aimed to identify opportunities for collaboration between research teams and industry to advance healthcare innovation projects.
To mark World Mental Health Day, the IGTP and HUGTiP podcast 'Un bri de ciència' releases its twelfth episode, featuring psychiatrist Jorge Cuevas. The conversation explores mental health, stigma and the importance of professional support, alongside research at Germans Trias into new models of psychiatric care.
IGTP welcomed a delegation of research organisations, universities and innovation stakeholders from Türkiye as part of a health-focused technical mission to Spain. The visit provided an opportunity to share expertise, explore potential collaborations and strengthen connections for future European research projects.
The Germans Trias Glaucoma Unit has become the first in Catalonia to achieve the highest level of GlauCCare accreditation, recognising its excellence in the care of people with glaucoma. Alongside specialised care, the unit collaborates with the Germans Trias i Pujol Research Institute (IGTP) on research and innovation projects aimed at improving the diagnosis and treatment of the disease.
Six leading institutions are joining forces across healthcare, research, education and innovation to create one of southern Europe's strongest cancer ecosystems. The new Consorci Oncològic Integral Nord Catalunya aims to achieve European certification as a Comprehensive Cancer Consortium and join the European network of excellence in oncology.
